Raloxifene: Risks and Benefits

@article{BarrettConnor2001RaloxifeneRA,
  title={Raloxifene: Risks and Benefits},
  author={E. Barrett-Connor},
  journal={Annals of the New York Academy of Sciences},
  year={2001},
  volume={949}
}
Abstract: Raloxifene, a selective estrogen receptor modulator (SERM), was designed to have the expected benefits of long‐term estrogen replacement therapy without the risks. This paper reviews the clinical trial evidence for raloxifene benefits and risks, and how they compare with those of hormone replacement therapy (HRT) and relate to the choices of postmenopausal women. 
32 Citations
Prevention of hormone-related cancers: breast cancer.
  • 64
Oestrogen receptors and linear bone growth
  • 31
Hormonal interventions to prevent hormonal cancers: breast and prostate cancers
  • B. Dunn, L. Ford
  • Medicine
  • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
  • 2007
  • 19
  • Highly Influenced
[Estrogen intracrinology: therapy and chemoprevention of breast cancer].
  • 3
  • PDF
Breast cancer and post-menopausal hormone therapy.
  • 40
...
1
2
3
4
...

References

SHOWING 1-10 OF 41 REFERENCES
...
1
2
3
4
5
...